Clinical Case Series - 24-cll-wm - Question 1

When managing the care of a patient with Waldenström macroglobulinemia receiving a BTK inhibitor, for which side effects would you feel more comfortable discontinuing (rather than dose reducing) therapy? (Select all that apply)

Musculoskeletal/rheumatologic
Hypertension and/or palpitations
Atrial fibrillation
Nail/skin/hair changes
Mucosal/gastrointestinal symptoms
Bruising/bleeding
Infection
Fatigue
Liver and renal dysfunction
Drug–drug interactions
{"name":"Clinical Case Series - 24-cll-wm - Question 1", "url":"https://www.poll-maker.com/QN6RRUD5F","txt":"When managing the care of a patient with Waldenström macroglobulinemia receiving a BTK inhibitor, for which side effects would you feel more comfortable discontinuing (rather than dose reducing) therapy? (Select all that apply)","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}
Tools: Poll Maker | Quiz Maker | Super Surveys